FDA.reportPublic FDA data

OraVerse 0.235 MG/ML per 1.7 ML Cartridge

RxCUI
1361021
RxNorm name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Display name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Full name
OraVerse 0.235 MG/ML per 1.7 ML Cartridge
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4025cf98-ea87-4531-b0fc-6283c84f63f31.7 ML phentolamine mesylate 0.235 MG/ML Cartridge [OraVerse]SBD4These highlights do not include all the information needed to use OraVerse™ safely and effectively. See full prescribing information for OraVerse. OraVerse (phentolamine mesylate) Injection Initial U.S. Approval: 195220181205
4025cf98-ea87-4531-b0fc-6283c84f63f3OraVerse 0.4 MG in 1.7 ML CartridgePSN4These highlights do not include all the information needed to use OraVerse™ safely and effectively. See full prescribing information for OraVerse. OraVerse (phentolamine mesylate) Injection Initial U.S. Approval: 195220181205
4025cf98-ea87-4531-b0fc-6283c84f63f3OraVerse 0.4 MG per 1.7 ML CartridgeSY4These highlights do not include all the information needed to use OraVerse™ safely and effectively. See full prescribing information for OraVerse. OraVerse (phentolamine mesylate) Injection Initial U.S. Approval: 195220181205
4025cf98-ea87-4531-b0fc-6283c84f63f3OraVerse 0.235 MG/ML per 1.7 ML CartridgeSY4These highlights do not include all the information needed to use OraVerse™ safely and effectively. See full prescribing information for OraVerse. OraVerse (phentolamine mesylate) Injection Initial U.S. Approval: 195220181205
38be9414-87c4-4a8a-9f17-99be0d0a33fa1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge [OraVerse]SBD120080523
38be9414-87c4-4a8a-9f17-99be0d0a33faOraVerse 0.4 MG per 1.7 ML CartridgeSY120080523
38be9414-87c4-4a8a-9f17-99be0d0a33faOraVerse 0.4 MG in 1.7 ML CartridgePSN120080523
38be9414-87c4-4a8a-9f17-99be0d0a33faOraVerse 0.235 MG/ML per 1.7 ML CartridgeSY120080523